Evidence map›Paper›PMID 25514797›Full record

ArticlePloS one2014

LOX-1 plays an important role in ischemia-induced angiogenesis of limbs.

Takeru Shiraki, Takuma Aoyama, Chiharu Yokoyama, Yuka Hayakawa, Toshiki Tanaka, Kazuhiko Nishigaki, Tatsuya Sawamura, Shinya Minatoguchi

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Takeru ShirakiDepartment of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan.
Takuma AoyamaDepartment of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan.
Chiharu YokoyamaDepartment of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan.
Yuka HayakawaDepartment of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan.
Toshiki TanakaDepartment of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan.
Kazuhiko NishigakiDepartment of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan.
Tatsuya SawamuraDepartment of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita, Japan; Department of Physiology, Shinshu University School of Medicine, Matsumoto, Japan.
Shinya MinatoguchiDepartment of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LOX-1, lectin-like oxidized low-density lipoprotein (LDL) receptor-1, is a single transmembrane receptor mainly expressed on endothelial cells. LOX-1 mediates the uptake of oxidized LDL, an early step in atherosclerosis; however, little is known about whether LOX-1 is involved in angiogenesis during tissue ischemia. Therefore, we examined the role of LOX-1 in ischemia-induced angiogenesis in the hindlimbs of LOX-1 knockout (KO) mice. Angiogenesis was evaluated in a surgically induced hindlimb ischemia model using laser Doppler blood flowmetry (LDBF) and histological capillary density (CD) and arteriole density (AD). After right hindlimb ischemia, the ischemic/nonischemic hindlimb blood flow ratio was persistently lower in LOX-1 KO mice than in wild-type (WT) mice. CD and AD were significantly smaller in LOX-1 KO mice than in WT mice on postoperative day 14. Immunohistochemical analysis revealed that the number of macrophages infiltrating ischemic tissues was significantly smaller in LOX-1 KO mice than in WT mice. The number of infiltrated macrophages expressing VEGF was also significantly smaller in LOX-1 KO mice than in WT mice. Western blot analysis and ROS production assay revealed that LOX- KO mice show significant decrease in Nox2 expression, ROS production and HIF-1α expression, the phosphorylation of p38 MAPK and NF-κB p65 subunit as well as expression of redox-sensitive vascular cell adhesion molecule-1 (VCAM-1) and LOX-1 itself in ischemic muscles, which is supposed to be required for macrophage infiltration expressing angiogenic factor VEGF. Reduction of VEGF expression successively suppressed the phosphorylation of Akt and eNOS, which accelerated angiogenesis, in the ischemic leg of LOX-1 KO mice. Our findings indicate that LOX-1 plays an important role in ischemia-induced angiogenesis by 1) Nox2-ROS-NF-κB activation, 2) upregulated expression of adhesion molecules: VCAM-1 and LOX-1 and 3) promoting macrophage infiltration, which expresses angiogenic factor VEGF.

Indexed as

AnimalsBlotting, WesternEnzyme ActivationExtremitiesGene Expression RegulationHypoxia-Inducible Factor 1, alpha SubunitImmunohistochemistryIschemiaLaser-Doppler FlowmetryMiceMice, KnockoutNeovascularization, PathologicReactive Oxygen SpeciesScavenger Receptors, Class EVascular Cell Adhesion Molecule-1Vascular Endothelial Growth Factor AHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitOlr1 protein, mouseReactive Oxygen SpeciesScavenger Receptors, Class EVascular Cell Adhesion Molecule-1Vascular Endothelial Growth Factor A

Identifiers

PMID25514797
PMCPMC4267738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.